Istituto Tumori Giovanni Paolo II IRCCS Ospedale Oncologico

Bari 70124

0 studies enrolling now · 1 studies all time

What they study most

Non Small Cell Lung Cancer

Studies at this site

• Taletrectinib Phase 2 Global Study in ROS1 Positive NSCLC — Running, not enrolling